News
The game is afoot in the obesity space as GLP-1 rivals Eli Lilly and Novo Nordisk take their showdown to a new level. Lilly ...
Vertex Pharmaceuticals should continue to beat the market. Any time is a great time to buy stocks -- if you pick the right ...
The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...
11h
WISH-TV on MSNAer Lingus flight marks new connection between Indianapolis and DublinThe first nonstop Aer Lingus flight from Dublin, Ireland landed Saturday night, but the long-term impact is just starting to take off.
Our writer explains why he just added to a big loser to his Stocks and Shares ISA portfolio, despite it going against one of ...
These three stocks could potentially help investors create a stable – and growing – stream of passive income in the years ...
13h
InsideHook on MSNWe're Getting Closer to Edible GLP-1 Drugs Being AvailablePop quiz: would you prefer to take a medication as a pill or inject yourself with it? Somehow, I suspect that the vast ...
16h
Audacy on MSNMerck invests $1B in Wilmington facility to boost U.S. drug production amid tariff concernsU.S. drug maker Merck is building a $1 billion facility in Wilmington, Delaware, aimed at increasing domestic production of ...
The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.
Key points A 28-year-old man with cocaine and alcohol use disorders presented to the emergency department with a 2-month history of worsening shortness of breath, orthopnea, and fatigue. His medical ...
Merck is injecting $1 billion into a new facility in Wilmington, Delaware to amp up U.S. drug production, especially for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results